Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-17-025024
Filing Date
2017-04-21
Accepted
2017-04-21 06:30:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 a17-11265_1424b3.htm 424B3 240534
2 GRAPHIC g112651bci001.jpg GRAPHIC 4655
3 GRAPHIC g112651bgi001.jpg GRAPHIC 36785
  Complete submission text file 0001104659-17-025024.txt   298907
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-217296 | Film No.: 17774173
SIC: 2834 Pharmaceutical Preparations